Related Experiment Video
Updated: May 14, 2026
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Sudden cardiac death associated with methylone use.
Peter N Carbone1, David L Carbone, Shaun D Carstairs
1Department of Anatomic Pathology, Naval Medical Center San Diego, San Diego, CA 92134, USA. peter.carbone@med.navy.mil
The American Journal of Forensic Medicine and Pathology
|February 14, 2013
Summary
Synthetic cathinone methylone, often marketed as "bath salts," has been linked to sudden cardiac death in a young man. Methylone toxicity may be underestimated, posing significant health risks despite lower detected concentrations than MDMA.
Area of Science:
- Forensic Toxicology
- Cardiovascular Pathology
Background:
- The increasing popularity of synthetic cathinones, such as methylone, as alternatives to illicit drugs necessitates toxicological evaluation.
- Synthetic cathinones are frequently encountered in emergency departments and forensic investigations.
Observation:
- A previously healthy 19-year-old male experienced sudden death following methylone use.
- Postmortem analysis revealed methylone in the blood at a concentration of 0.07 mg/dL.
Findings:
- This case represents the first reported instance of sudden cardiac death definitively linked to methylone.
- Detected methylone levels were lower than those typically associated with MDMA-related fatalities, suggesting potent toxicity.
Implications:
- Methylone's potential for causing fatal cardiac events may be significantly underestimated.
- This case highlights the critical need for increased awareness and toxicological scrutiny of synthetic cathinones.
- Further research is warranted to fully elucidate the cardiovascular risks associated with methylone and related compounds.
Related Concept Videos
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Toxidromes: Clinical Features
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...